NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

NCT06299163 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Ovarian Carcinoma
Fallopian Tube Carcinoma
Peritoneal Carcinoma
Endometrial Cancer
Adenocarcinoma of Lung
Triple Negative Breast Cancer
Liposarcoma
Leiomyosarcoma
Mesothelioma, Malignant
Adenocarcinoma - Gastroesophageal Junction (GEJ)
Adenocarcinoma of the Stomach
Melanoma, Malignant
Renal Cell Carcinoma

Interventions

BIOLOGICAL: NM32-2668

Sponsor

Numab Therapeutics AG